HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Juvena/La Prairie

This article was originally published in The Rose Sheet

Executive Summary

Juvena skin care will be integrated into Volketswil, Switzerland-based La Prairie Group, a division that also will now include European brands Marlies Möller Beauty Hair Care and SBT Skin Biology Therapy, Beiersdorf announces. "The association of the brands under one name means that we may join forces, build on our strengths and thereby enhance the potential of each of our individual brands," according to La Prairie Group President and CEO Dirk Trappmann. La Prairie"will continue to expand to new markets and will intensify its efforts in high-potential business areas, such as Travel Retail/Duty Free and the Asian region," while Juvena will "focus on its European and American business, building on the success of its Juvedical line," company notes. Juvedical skin care launched in the U.S. in February 2005 and will expand this year to include body care (1"The Rose Sheet" Dec. 5, 2005, p. 9)...

You may also be interested in...



Skin Care In Brief

Juvena: Juvedical skin care collection will expand next year to include Renewing Body Cream and Renewing Body Serum, Beiersdorf division says. Formulas feature brand's Skin Nova technology, based on a burn treatment method, which helps skin repair itself, according to the firm. Serum, which will cost $85, includes "polymers embedded in water which form a 3-dimentional network that retains the right amount of lipids to keep the body hydrated," Juvena claims. Retailing for $63, cream helps skin rebuild lipid barrier and nourishes, making skin appear smoother, company says. Products are designed to "alleviate discomfort caused by breakouts from waxing treatments or shaving irritation, aid in the recovery process of patients who have undergone cosmetic surgery, and diminish unwanted stretch marks from weight fluctuations or pregnancy," Beiersdorf notes. Juvedical debuted earlier this year with the launch of a day cream, night cream and face serum, and the line recently expanded to include eye serum and eye cream (1"The Rose Sheet" Nov. 29, 2004, p. 5 and 2"The Rose Sheet" Aug. 22, 2005, Marketing in Brief). Line is carried in Bath & Body Works flagship stores, CO Bigelow, select Nordstrom stores and boutiques and on Sephora.com...

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013690

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel